IL118422A0 - Use of alendronate for the prevention of osteoporosis - Google Patents

Use of alendronate for the prevention of osteoporosis

Info

Publication number
IL118422A0
IL118422A0 IL11842296A IL11842296A IL118422A0 IL 118422 A0 IL118422 A0 IL 118422A0 IL 11842296 A IL11842296 A IL 11842296A IL 11842296 A IL11842296 A IL 11842296A IL 118422 A0 IL118422 A0 IL 118422A0
Authority
IL
Israel
Prior art keywords
alendronate
osteoporosis
prevention
Prior art date
Application number
IL11842296A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL118422A0 publication Critical patent/IL118422A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11842296A 1995-06-02 1996-05-27 Use of alendronate for the prevention of osteoporosis IL118422A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
IL118422A0 true IL118422A0 (en) 1996-09-12

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11842296A IL118422A0 (en) 1995-06-02 1996-05-27 Use of alendronate for the prevention of osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (en)
JP (1) JPH10506648A (en)
KR (1) KR19990022436A (en)
CN (1) CN1192685A (en)
AU (1) AU709196B2 (en)
BG (1) BG63103B1 (en)
BR (1) BR9609020A (en)
CA (1) CA2222318A1 (en)
CZ (1) CZ381197A3 (en)
EA (1) EA000677B1 (en)
EE (1) EE03306B1 (en)
HU (1) HUP9900659A3 (en)
IL (1) IL118422A0 (en)
IS (1) IS4617A (en)
NO (1) NO975527D0 (en)
NZ (1) NZ308935A (en)
PL (1) PL323669A1 (en)
SK (1) SK159597A3 (en)
TR (1) TR199701482T1 (en)
WO (1) WO1996038156A1 (en)
ZA (1) ZA964465B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (en) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
EP1392325B1 (en) * 2001-05-02 2006-06-21 Novartis AG Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
JP2010043119A (en) * 2009-10-16 2010-02-25 Gador Sa Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
KR102472749B1 (en) * 2022-01-18 2022-12-02 주식회사 위엔씨 Manufacturing method of adsorption material with harmful gas removal antibacterial and deodorizing functions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
AU5882496A (en) 1996-12-18
KR19990022436A (en) 1999-03-25
EA000677B1 (en) 2000-02-28
TR199701482T1 (en) 1998-03-21
SK159597A3 (en) 1998-06-03
PL323669A1 (en) 1998-04-14
IS4617A (en) 1997-11-19
NO975527L (en) 1997-12-01
EE03306B1 (en) 2000-12-15
BR9609020A (en) 1999-07-06
AU709196B2 (en) 1999-08-26
WO1996038156A1 (en) 1996-12-05
ZA964465B (en) 1996-12-11
JPH10506648A (en) 1998-06-30
BG63103B1 (en) 2001-04-30
HUP9900659A3 (en) 2002-12-28
NO975527D0 (en) 1997-12-01
HUP9900659A2 (en) 2001-04-28
CZ381197A3 (en) 1998-06-17
CN1192685A (en) 1998-09-09
EA199700449A1 (en) 1998-06-25
NZ308935A (en) 2000-07-28
EP0828496A1 (en) 1998-03-18
BG102060A (en) 1998-07-31
CA2222318A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
ZA95556B (en) Combination treatment for osteoporosis
GB9508810D0 (en) Compounds
GB9500691D0 (en) Compounds
GB9504910D0 (en) Compounds
ZA964465B (en) Use of alendronate for the prevention of osteoporosis
GB9504948D0 (en) Compounds
GB9502540D0 (en) Compounds
IL117969A0 (en) Inhibiting photodecomposition of 3-substituted-2-oxinoles
IL110183A0 (en) Osteoporosis prevention apparatus
SI1175904T1 (en) Alendronate for use in the treatment of osteoporosis
GB9521934D0 (en) Device for the location of fasteneres
GB9716883D0 (en) Combination therapy for the prevention and treatent of osteoporosis
GB9504190D0 (en) Compounds
GB9508874D0 (en) Compounds
GB9502983D0 (en) Compounds
GB9503211D0 (en) Compounds
GB9501581D0 (en) Compounds
GB9504802D0 (en) Compounds
GB9504907D0 (en) Compounds
GB9502784D0 (en) Compounds
GB9501580D0 (en) Compounds
GB9502783D0 (en) Compounds
GB9504990D0 (en) Compounds
GB9506168D0 (en) Compounds
GB9506169D0 (en) Compounds